1. A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes. (March 2018) Authors: Ferrer, Pedro E; Bloch, Mark; Roth, Norman; Finlayson, Robert; Baker, David; Koh, Ken; Orth, David; Urbaityte, Rimgaile; Brown, Dannae; Drummond, Fraser Journal: International journal of STD & AIDS Issue: Volume 29:Number 3(2018) Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. (18th May 2016) Authors: Martinello, Marianne; Dore, Gregory J.; Skurowski, Jasmine; Bopage, Rohan I.; Finlayson, Robert; Baker, David; Bloch, Mark; Matthews, Gail V. Journal: Open forum infectious diseases Issue: Volume 3:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study. Issue 8 (August 2021) Authors: Grulich, Andrew E; Jin, Fengyi; Bavinton, Benjamin R; Yeung, Barbara; Hammoud, Mohamed A; Amin, Janaki; Cabrera, Gesalit; Clackett, Shawn; Ogilvie, Erin; Vaccher, Stefanie; Vickers, Tobias; McNulty, Anna; Smith, David J; Dharan, Nila J; Selvey, Christine; Power, Cherie; Price, Karen; Zablotska, I... Journal: Lancet Issue: Volume 8:Issue 8(2021) Page Start: e486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV. (15th July 2020) Authors: Hosseini-Hooshyar, Samira; Martinello, Marianne; Yee, Jasmine; Read, Phillip; Baker, David; Post, Jeffrey J.; Finlayson, Robert; Bloch, Mark; Doyle, Joseph S.; Shaw, David; Hellard, Margaret; Petoumenos, Kathy; Carson, Joanne; Dore, Gregory J.; Matthews, Gail V. Journal: AIDS Issue: Volume 34:Number 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study. (4th October 2019) Authors: Martinello, Marianne; Yee, Jasmine; Bartlett, Sofia R; Read, Phillip; Baker, David; Post, Jeffrey J; Finlayson, Robert; Bloch, Mark; Doyle, Joseph; Shaw, David; Hellard, Margaret; Petoumenos, Kathy; Lin, Lanni; Marks, Philippa; Applegate, Tanya; Dore, Gregory J; Matthews, Gail V Journal: Clinical infectious diseases Issue: Volume 71:Number 6(2020) Page Start: 1502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NKT cell depletion in humans during early HIV infection. Issue 7 (29th April 2014) Authors: Fernandez, Caroline S; Kelleher, Anthony D; Finlayson, Robert; Godfrey, Dale I; Kent, Stephen J Journal: Immunology and cell biology Issue: Volume 92:Issue 7(2014) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P099 Renal Safety of Tenofovir Alafenamide in Patients at High Risk of Kidney Disease. (30th June 2016) Authors: Waters, Laura; Wohl, David; Thalme, Anders; Finlayson, Robert; Oka, Shinichi; Das, Moupali; Yau, Stuart; Fordyce, Marshall Journal: Sexually transmitted infections Issue: Volume 92(2016)Supplement 1 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort. Issue 5 (18th August 2022) Authors: Bartlett, Sofia R.; Verich, Andrey; Carson, Joanne; Hosseini‐Hooshyar, Samira; Read, Phillip; Baker, David; Post, Jeffrey J.; Finlayson, Robert; Bloch, Mark; Doyle, Joseph S.; Shaw, David; Hellard, Margaret; Martinez, Maria; Marks, Philippa; Dore, Gregory J.; Matthews, Gail V.; Applegate, Tanya; ... Journal: Health science reports Issue: Volume 5:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Issue 11 (November 2018) Authors: Grulich, Andrew E; Guy, Rebecca; Amin, Janaki; Jin, Fengyi; Selvey, Christine; Holden, Jo; Schmidt, Heather-Marie A; Zablotska, Iryna; Price, Karen; Whittaker, Bill; Chant, Kerry; Cooper, Craig; McGill, Scott; Telfer, Barbara; Yeung, Barbara; Levitt, Gesalit; Ogilvie, Erin E; Dharan, Nila J; Hamm... Journal: Lancet Issue: Volume 5:Issue 11(2018) Page Start: e629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data. Issue 8 (August 2022) Authors: Traeger, Michael W; Guy, Rebecca; Asselin, Jason; Patel, Prital; Carter, Allison; Wright, Edwina J; Grulich, Andrew; McManus, Hamish; Fairley, Christopher K; Chow, Eric P F; McNulty, Anna; Finlayson, Robert; Bell, Charlotte; Owen, Louise; Marshall, Lewis; Russell, Darren; O'Donnell, Darryl; Donov... Journal: Lancet infectious diseases Issue: Volume 22:Issue 8(2022) Page Start: 1231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗